Cara Janice Almquist, | |
3960 Coon Rapids Blvd Nw Ste 123, Coon Rapids, MN 55433-2521 | |
(763) 236-7337 | |
Not Available |
Full Name | Cara Janice Almquist |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 3960 Coon Rapids Blvd Nw Ste 123, Coon Rapids, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508516469 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cara Janice Almquist, 3960 Coon Rapids Blvd Nw Ste 123, Coon Rapids, MN 55433-2521 Ph: (763) 236-7337 | Cara Janice Almquist, 3960 Coon Rapids Blvd Nw Ste 123, Coon Rapids, MN 55433-2521 Ph: (763) 236-7337 |
News Archive
Baxter International Inc. today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of Emergency Physicians (ACEP) scientific assembly (Boston). HYLENEX, an enzyme, allows fluids to be administered under the skin (subcutaneously) rather than through a vein.
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.
› Verified 3 days ago
Sahaam Ahmed Abdi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9120 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 612-400-6171 | |
Valerie Marquardt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-8920 | |
Megan Dallas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9120 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 612-400-6118 | |
Lisa Marie Rickert, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3111 124th Ave Nw Ste 123, Coon Rapids, MN 55433 Phone: 763-236-7337 | |
Amy Janice Bergsbaken, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Coon Rapids Blvd Nw, Suite 200, Coon Rapids, MN 55433 Phone: 763-767-0854 Fax: 763-862-6533 | |
Debra Ann Holmquist, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3111 124th Ave Nw Ste 123, Coon Rapids, MN 55433 Phone: 763-236-7337 | |
Kelli Timinski, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-8749 |